Leading the Way in Russian Law
 


LEGAL UPDATES

more legal updates

PUBLICATIONS

more publications

EVENTS

more events

RECENT DEALS

Legal support of the fund established by inheritors of the famous Tove Jansson in monitoring online and offline infringements and protecting their copyrights to Moomin characters in Russia
more recent deals


RSS  RSS Feed to News

NEWS & PRESS RELEASES  |  ARTICLES  |  BOOKS  |  LEGAL UPDATES  |  MEDIA ROOM  |  RSS FEEDS  |  SUBSCRIBE


Lidings: New Client Wins in Pharmaceuticals and Healthcare


 
Lidings continues to affirm its reputation as a leading legal advisor to the pharmaceuticals sector in Russia. The firm has been engaged to advise a large Swiss biopharmaceutical manufacturer Actelion, and a well-known Latvian company Grindex, leading pharmaceutical company in the Baltic states.
 
“One of the important things to acknowledge when advising pharmaceutical companies is the wide range of legal issues your clients are facing in their day to day activities”, comments Andrey Zelenin, partner and head of Pharmaceuticals and Healthcare practice at Lidings. “By way of an example, both clients mentioned above placed their requests for legal counsel following increase in their marketing efforts in the Russian market. Our advice in these cases covered interaction with medical representatives and practical effects of the applicable restrictions, as well as advice on entering into co-marketing agreements with another company well-represented in Russia”.
 
Actelion Pharmaceuticals was founded in December 1997 and has its headquarters in near Basel in Switzerland. The company specializes in orphan diseases, and its scientists were among the first to work in the field of endothelian receptor antagonists. Actelion has has 29 operative affiliates around the world, including the United States, Canada, Brazil, Australia, Japan, Switzerland and a number of EU countries. In 2006, the company established the Actelion Endothelin Research Award programme which supports selected clinical research projects.
 
Grindeks is the leading pharmaceutical company in the Baltic States. Main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. The company specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups. Grindeks Group consists of 4 subsidiary companies in Latvia, Estonia and Russia; representative offices are opened in 13 countries. Products are exported to 59 countries; export comprises 95% of the total turnover. The main markets are the Baltic States, Russia and other CIS countries, Germany, the Netherlands, Japan and USA. 
 
Lidings is ranked by reputable international ranking agencies as leading life sciences practice in Russia.  Partner, head of practice Andrey Zelenin was repeatedly named the best lawyer in the sphere of life sciences in Russia by the leading international legal directory Who is Who Legal. Chambers and Partner Europe has recently published the results of its annual research where it recommends Lidings as top legal advisor to the life sciences sector, awarding personal recognition to Andrey Zelenin and praising his professional expertise in the field: “The team handles both contentious and non-contentious work in the life sciences sector, advises on regulatory, tax and contractual issues, provides specialist support on clinical trials. Notable practitioners include Andrey Zelenin, a litigator and arbitrator with a growing life sciences practice”. 
 

back to News & Press Releases   |   print page



TOP M&A
Legal Advisor
in Russia


Recommended in
All Key Practice Areas


Recommended Firm
for Dispute Resolution
in Russia


Best Life Sciences
Practice in Russia


Best Life Sciences practice,
recommended in corporate 

and M&A, dispute resolution 
in Russia


The Most Visible
Russian Law Firm


Recommended in
Key Practice Areas

Open Partnership: 
an inside look